West Virginia 2025 Regular Session

West Virginia Senate Bill SB723

Introduced
3/7/25  
Refer
3/7/25  
Refer
3/13/25  
Engrossed
4/2/25  
Refer
4/3/25  

Caption

Relating to clinical inpatient medical treatment centers for substance use disorder

Impact

The bill is expected to have a significant impact on state laws related to healthcare and addiction treatment. By enforcing a requirement that at least 85% of patients be West Virginia residents, it prioritizes local access to treatment services. The bill also stipulates that facilities are responsible for transitioning graduates into suitable ongoing care, thus promoting sustained recovery. Furthermore, by managing reporting requirements and compliance measures, the bill holds facilities accountable for delivering quality care and reducing the likelihood of patients relapsing.

Summary

Senate Bill 723 focuses on establishing regulations for clinical inpatient medical treatment centers for individuals struggling with substance use disorders in West Virginia. The bill outlines specific requirements for these facilities, including the percentage of patients that must be residents of West Virginia and mandates institutions to implement an integrated care model that includes a variety of health services. It aims to improve access to treatment and ensure accountability by requiring centers to submit quarterly reports to the West Virginia Office of the Inspector General regarding their operations and compliance with the new standards.

Sentiment

Discussions surrounding SB 723 suggest a generally supportive sentiment among legislators who advocate for improved addiction treatment services. Proponents argue that the bill reflects a necessary response to the state's ongoing substance abuse crisis and emphasizes the importance of local treatment accessibility. However, there could be contentions regarding the bill's feasibility and the potential challenges faced by treatment centers in meeting the mandated requirements, particularly within the context of funding and resource availability.

Contention

Notable points of contention include concerns over the feasibility of the new reporting requirements and whether all facilities can maintain compliance without additional resources. Some stakeholders might fear that the stringent regulations could inadvertently restrict access to necessary treatment services for those in need or place undue burdens on providers, particularly smaller or rural facilities that lack sufficient resources. The debate is likely to continue as stakeholders balance the need for accountability and quality care against the realities faced by treatment centers across West Virginia.

Companion Bills

No companion bills found.

Similar Bills

NM HB152

Medically Assisted Treatment For Juveniles

MO SB218

Modifies the provisions relating to the establishment of treatment courts by providing for a mental health treatment court

NH HB751

Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.

MS HB718

Opioid use disorder; require substance use disorder facilities to provide pregnant women with onsite access to certain treatments.

NJ S3955

Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

MA H2227

Replacing archaic and stigmatizing language for substance use

NJ A3974

Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

IN SB0446

Mental health and substance abuse coverage.